Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Lowered to $200 at Piper Sandler

August 8, 2024 7:41 AM
Piper Sandler analyst Biren Amin lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $200.00 (from $205.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles